Reports

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Companion Animal Vaccine Market: By Vaccines: Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Others; By Animal Type; By Disease; By Distribution Channel; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Companion Animal Vaccine Market Outlook

The global companion animal vaccine market is expected to grow at a CAGR of 6.2% during the period 2022-2027. The market is expected to be driven by the growing rate of adoption of companion animals, including rabbits, dogs, cats, etc. In recent years, some European countries have witnessed a significant increase in pet adoption. Pets or companion animals offer humans much needed interaction that offers social, medical, emotional and physical benefits. North America, Europe and Asia are expected to be key markets.

 

Global Companion Animal Vaccine Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Global Market Likely to be Driven by Advancements in Treatment Systems

Differing customer needs across regions characterize the animal health medicines, vaccines and diagnostics market space.  Factors include economic differences (standards of living in developing versus developed nations), cultural differences (including dietary preferences for separate animal proteins, pet ownership preferences and standards of pet care), epidemiological differences (for example, prevalence of particular bacterial and viral strains and aspects of  diseases), treatment differences (utilization of various types of vaccines and medicines, and rate of adoption of novel  technologies), environmental differences (seasonality, climate and the availability of arable land and fresh water), and regulatory differences.

Growth in the companion animal vaccines sector is propelled by economic development, associated increase in disposable income, and rise in pet ownership and expenditure on pet care. Advancements in animal health medicines, vaccines and diagnostics have led to longer lives of companion animals.

Vaccination has been an effective method to decrease disease burden in companion animals, pets and farm animals, and maintaining animal health and welfare. Vaccines play a crucial role in preventative health and disease control programmes in animals. Continual research, innovations and development of safe, effective and quality vaccines have enhanced protection for pets and farm animals. These developments are expected to stimulate the global companion animal vaccine market.

 

Effective Vaccines Available for Several Important Animal Diseases Likely to Boost Market Growth

Companion animals, pets and farm animals are susceptible to several diseases caused by viruses, bacteria, fungi and parasites. Today, vaccines come for many of these diseases, making it possible to prevent the diseases or minimizing the losses or long-term effects associated with the diseases. This assumes all the more importance when those diseases are considered that are complex, with limited or no available treatment alternatives.

Encouragingly, effective vaccines are nowadays available for several important animal diseases. The animal medicines sector continues to invest in research and development of veterinary vaccines to counter the various types of endemic and exotic diseases. A significant achievement in veterinary medicine in modern times includes the global eradication of a damaging livestock disease – Rinderpest – in 2011; vaccination played a key role therein. Modern veterinary vaccines are a result of several years of research and innovation, and meet multiple disease threats to pets, companion animals and farm animals. Vaccines stimulate immune responses in animals without causing the disease itself.

Main types of existing vaccines may be categorised as follows:

Modified-live (attenuated) – Such a vaccine carries an intact but weakened pathogen; the pathogen stimulates an immune response without causing clinical disease.

Inactivated (killed) – Such a vaccine carries a completely inactivated pathogen (the pathogen is no longer infectious), and generally contains an adjuvant (an added compound to help enhance protective immune response).

Recombinant – A vaccine produced with the help of genetic engineering technology, employing specific genetic material from a pathogen to make proteins to stimulate an immune response in animals after vaccination.

Toxoid – A vaccine based on inactivated toxins made by pathogens. These vaccines stimulate immunity and offer animals protection against these toxins. Through research and innovation, modern and sophisticated technologies like marker vaccines have been developed.

The development of different types of effective vaccines is expected to boost the global companion animal vaccine market.

 

Effective Vaccination can Prevent, Control or Alleviate Several Diseases in Companion Animals

Vaccines protect companion animals from a variety of diseases. Effective vaccination can prevent, control or alleviate several diseases in cats, including Feline Panleukopenia/Infectious Enteritis (Feline Panleukopenia or Parvovirus, FPV), Feline Rhinotracheitis (Feline Herpesvirus, FHV), Feline Calicivirus (FCV), Feline Leukaemia Virus (FeLV), Chlamydophila felis, and Feline Rabies, among others.

Significant canine diseases for which vaccines are available include Canine Distemper Virus (CDV), Canine Parvovirus (CPV), Canine Adenovirus (CAV), Canine Leptospira, Canine parainfluenza virus (CPi), Bordetella bronchiseptica, and Canine Rabies, among others.

Vaccines protect rabbits from two serious viral infectious diseases – myxomatosis and rabbit haemorrhagic disease.

Farm animals include species such as cattle, sheep, pigs, poultry, and farmed fish. This implies a wide range of potential disease threats, and vaccines are available to protect these farm animals.

Horses, in the form of companion animals, athletes and breeding stock, are exposed to multiple disease threats, according to their unique circumstances. Important equine vaccines include Equine Influenza, Tetanus, Equine Herpes Virus 1 and 4 (EHV-1 and EHV4), among others.

 

Global Companion Animal Vaccine Market Segmentation

 

Global Companion Animal Vaccine Market by Segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

By vaccines, the market is segmented into:

  • Live Attenuated Vaccines
  • Inactivated Vaccines 
  • Toxoid Vaccines
  • Recombinant Vaccines
  • Subunit Vaccine
  • Conjugate Vaccine
  • DNA Vaccine
  • Others

By animal type, the market is divided into:

  • Feline
  • Canine
  • Bovine
  • Others

By disease, the market is classified into:

  • Rabies
  • Hepatitis
  • Leukemia
  • Others

By distribution channel, the market is segmented into:

  • Veterinary Clinics
  • Veterinary Hospitals 
  • Veterinary Research Institutes
  • Retail Pharmacies
  • Others

By region, the market is classified into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

 

Global Companion Animal Vaccine Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Key Industry Players in the Global Companion Animal Vaccine Market

The report presents a detailed analysis of the following key players in the market, looking into their capacity, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Boehringer Ingelheim
  • Intervet Inc. (Merck Animal Health)
  • Zoetis Services LLC
  • Bioveta, a.s.
  • Elanco Animal Health Incorporated
  • Zoetis Inc
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2021
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Vaccines
  • Animal Type
  • Disease
  • Distribution Channel
  • Region
Breakup by Vaccines
  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • Subunit Vaccine
  • Conjugate Vaccine
  • DNA Vaccine
  • Others 
Breakup by Animal Type
  • Feline
  • Canine
  • Bovine
  • Others
Breakup by Disease
  • Rabies
  • Hepatitis
  • Leukemia
  • Others
Breakup by Distribution Channel
  • Veterinary Clinics
  • Veterinary Hospitals
  • Veterinary Research Institutes
  • Retail Pharmacies
  • Others
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT
  • Porter's Five Forces
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Boehringer Ingelheim
  • Intervet Inc. (Merck Animal Health)
  • Zoetis Services LLC
  • Bioveta, a.s.
  • Elanco Animal Health Incorporated
  • Zoetis Inc
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Companion Animal Vaccines Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Companion Animal Vaccines Historical Market (2017-2021) 
    8.3    Global Companion Animal Vaccines Market Forecast (2022-2027)
    8.4    Global Companion Animal Vaccines Market by Vaccines
        8.4.1    Live Attenuated Vaccines
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    Inactivated Vaccines 
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027) 
        8.4.3    Toxoid Vaccines
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
        8.4.4    Recombinant Vaccines
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2017-2021)
            8.4.4.3    Forecast Trend (2022-2027)
        8.4.5    Subunit Vaccine
            8.4.5.1    Market Share
            8.4.5.2    Historical Trend (2017-2021)
            8.4.5.3    Forecast Trend (2022-2027)
        8.4.6    Conjugate Vaccine
            8.4.6.1    Market Share
            8.4.6.2    Historical Trend (2017-2021)
            8.4.6.3    Forecast Trend (2022-2027)
        8.4.7    DNA Vaccine
            8.4.7.1    Market Share
            8.4.7.2    Historical Trend (2017-2021)
            8.4.7.3    Forecast Trend (2022-2027)
        8.4.8    Others 
    8.5    Global Companion Animal Vaccines Market by Animal Type
        8.5.1    Feline
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Canine
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
        8.5.3    Bovine
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2017-2021)
            8.5.3.3    Forecast Trend (2022-2027)
        8.5.4    Others
    8.6    Global Companion Animal Vaccines Market by Disease
        8.6.1    Rabies
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021)
            8.6.1.3    Forecast Trend (2022-2027)
        8.6.2    Hepatitis
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021)
            8.6.2.3    Forecast Trend (2022-2027)
        8.6.3    Leukemia
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2017-2021)
            8.6.3.3    Forecast Trend (2022-2027)
        8.6.4    Others
    8.7    Global Companion Animal Vaccines Market by Distribution Channel
        8.7.1    Veterinary Clinics
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2017-2021)
            8.7.1.3    Forecast Trend (2022-2027)
        8.7.2    Veterinary Hospitals 
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2017-2021)
            8.7.2.3    Forecast Trend (2022-2027) 
        8.7.3    Veterinary Research Institutes
            8.7.3.1    Market Share
            8.7.3.2    Historical Trend (2017-2021)
            8.7.3.3    Forecast Trend (2022-2027)
        8.7.4    Retail Pharmacies
            8.7.4.1    Market Share
            8.7.4.2    Historical Trend (2017-2021)
            8.7.4.3    Forecast Trend (2022-2027)
        8.7.5    Others
    8.8    Global Companion Animal Vaccines Market by Region
        8.8.1    Market Share
            8.8.1.1    North America
            8.8.1.2    Europe
            8.8.1.3    Asia Pacific
            8.8.1.4    Latin America
            8.8.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Competitive Landscape
    11.1    Market Structure
    11.2    Company Profiles
        11.2.1    Boehringer Ingelheim
            11.2.1.1    Company Overview
            11.2.1.2    Product Portfolio
            11.2.1.3    Demographic Reach and Achievements
            11.2.1.4    Certifications
        11.2.2    Intervet Inc. (Merck Animal Health)
            11.2.2.1    Company Overview
            11.2.2.2    Product Portfolio
            11.2.2.3    Demographic Reach and Achievements
            11.2.2.4    Certifications
        11.2.3    Zoetis Services LLC
            11.2.3.1    Company Overview
            11.2.3.2    Product Portfolio
            11.2.3.3    Demographic Reach and Achievements
            11.2.3.4    Certifications
        11.2.4    Bioveta, a.s.
            11.2.4.1    Company Overview
            11.2.4.2    Product Portfolio
            11.2.4.3    Demographic Reach and Achievements
            11.2.4.4    Certifications
        11.2.5    Elanco Animal Health Incorporated
            11.2.5.1    Company Overview
            11.2.5.2    Product Portfolio
            11.2.5.3    Demographic Reach and Achievements
            11.2.5.4    Certifications
        11.2.6    Zoetis Inc
            11.2.6.1    Company Overview
            11.2.6.2    Product Portfolio
            11.2.6.3    Demographic Reach and Achievements
            11.2.6.4    Certifications
        11.2.7    Others
12    Industry Events and Developments

 

List of Figures and Tables

1.    Global Companion Animal Vaccines Market: Key Industry Highlights, 2017 and 2021
2.    Global Companion Animal Vaccines Historical Market: Breakup by Vaccines (USD Million), 2017-2021
3.    Global Companion Animal Vaccines Market Forecast: Breakup by Vaccines (USD Million), 2022-2027
4.    Global Companion Animal Vaccines Historical Market: Breakup by Animal Type (USD Million), 2017-2021
5.    Global Companion Animal Vaccines Market Forecast: Breakup by Animal Type (USD Million), 2022-2027
6.    Global Companion Animal Vaccines Historical Market: Breakup by Disease (USD Million), 2017-2021
7.    Global Companion Animal Vaccines Market Forecast: Breakup by Disease (USD Million), 2022-2027
8.    Global Companion Animal Vaccines Historical Market: Breakup by Distribution Channel (USD Million), 2017-2021
9.    Global Companion Animal Vaccines Market Forecast: Breakup by Distribution Channel (USD Million), 2022-2027
10.    Global Companion Animal Vaccines Historical Market: Breakup by Region (USD Million), 2017-2021
11.    Global Companion Animal Vaccines Market Forecast: Breakup by Region (USD Million), 2022-2027
12.    North America Companion Animal Vaccines Historical Market: Breakup by Country (USD Million), 2017-2021
13.    North America Companion Animal Vaccines Market Forecast: Breakup by Country (USD Million), 2022-2027
14.    Europe Companion Animal Vaccines Historical Market: Breakup by Country (USD Million), 2017-2021
15.    Europe Companion Animal Vaccines Market Forecast: Breakup by Country (USD Million), 2022-2027
16.    Asia Pacific Companion Animal Vaccines Historical Market: Breakup by Country (USD Million), 2017-2021
17.    Asia Pacific Companion Animal Vaccines Market Forecast: Breakup by Country (USD Million), 2022-2027
18.    Latin America Companion Animal Vaccines Historical Market: Breakup by Country (USD Million), 2017-2021
19.    Latin America Companion Animal Vaccines Market Forecast: Breakup by Country (USD Million), 2022-2027
20.    Middle East and Africa Companion Animal Vaccines Historical Market: Breakup by Country (USD Million), 2017-2021
21.    Middle East and Africa Companion Animal Vaccines Market Forecast: Breakup by Country (USD Million), 2022-2027
22.    Global Companion Animal Vaccines Market Structure

Key Questions Answered in the Report

The global companion animal vaccine market is projected to grow at a CAGR of 6.2% between 2022 and 2027.

The major drivers of the market include the economic development, associated increase in disposable income, rise in pet ownership, expenditure on pet care, and advancements in animal health medicines, vaccines.

The growing rate of adoption of companion animals and advancements in treatment systems are the key industry trends propelling the market's growth.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The different vaccines in the market are live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines, subunit vaccine, conjugate vaccine, and DNA vaccine, among others.

Based on animal type, the market is divided into feline, canine, and bovine, among others.

The various diseases in the market are rabies, hepatitis, and leukemia, among others.

The several distribution channels are veterinary clinics, veterinary hospitals, veterinary research institutes, and retail pharmacies, among others.

The major players in the industry are Boehringer Ingelheim, Intervet Inc. (Merck Animal Health), Zoetis Services LLC, Bioveta, a.s., Elanco Animal Health Incorporated, and Zoetis Inc, among others.

Analyst Review

The global companion animal vaccine market was driven by the growing rate of adoption of companion animals in the historical period. Aided by the rise in pet ownership and advancements in treatment systems, the market is expected to witness further growth in the forecast period of 2022-2027, growing at a CAGR of 6.2%.

EMR's meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. The different vaccines in the market are live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines, subunit vaccine, conjugate vaccine, and DNA vaccine, among others. Based on animal type, the market is divided into feline, canine, and bovine, among others. The various diseases in the market are rabies, hepatitis, and leukemia, among others. The several distribution channels are veterinary clinics, veterinary hospitals, veterinary research institutes, and retail pharmacies, among others. The major regional markets for companion animal vaccine are North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa. The major players in the industry are Boehringer Ingelheim, Intervet Inc. (Merck Animal Health), Zoetis Services LLC, Bioveta, a.s., Elanco Animal Health Incorporated, and Zoetis Inc, among others.

EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER